Physician profile
Eric Salazar
NPI 1861751133
$596.16
in general payments reported to CMS, 2019-2025
13 companies · $408 in 2025
The $408 reported for 2025 was more than what 85% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $15.16 · 2021: $13.84 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311 · Travel and Lodging: $97.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.59 |
| Travel and Lodging | $97.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Werfen USA LLC | $391.41 | 2025 | |
| Abiomed | $52.93 | 2019 | |
| Agios Pharmaceuticals, INC. | $29.21 | 2019 | |
| Celgene Corporation | $22.03 | 2019 | |
| Abbott Laboratories | $17.08 | 2025 | Alinity |
| Rigel Pharmaceuticals, INC. | $16.05 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.16 | 2020 | |
| Janssen Biotech, INC. | $14.28 | 2019 | |
| Medtronic, INC. | $13.84 | 2021 | |
| Array Biopharma INC | $12.69 | 2019 | |
| Incyte Corporation | $11.48 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Salazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.